https://www.selleckchem.com/products/cpypp.html
Patients 40 years were more likely to receive biological DMARDs, while those ≥70 years more often received only GC treatment. There were significant age- and sex-dependent differences in the medical treatment and in outcome of RA 8 years after diagnosis. The differences were most pronounced in men40 and women ≥70 years, but whether they are due to disease phenotype or treatment is unclear. There were significant age- and sex-dependent differences in the medical treatment and in outcome of RA 8 years after diagnosis. The difference
Like
Comment
Share
